| Dr John J Wilson, MD | |
|
2100 Wescott Dr, Flemington, NJ 08822-4603 | |
| (609) 429-0054 | |
| Not Available |
| Full Name | Dr John J Wilson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 2100 Wescott Dr, Flemington, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861559528 | NPI | - | NPPES |
| 01417174 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 192403 (New York) | Secondary |
| 207L00000X | Anesthesiology | 25MA06319000 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John J Wilson, MD Po Box 326, Franklin Lakes, NJ 07417-0326 Ph: (609) 429-0054 | Dr John J Wilson, MD 2100 Wescott Dr, Flemington, NJ 08822-4603 Ph: (609) 429-0054 |
News Archive
Oregon Health & Science University Cancer Institute researcher Jeff Tyner, Ph.D., has created a way to identify proteins that are candidates for targeted therapy in acute myeloid leukemia using an assay that yields results in just four days.
Cardium Therapeutics today reported that a recent medical journal article highlights the challenges facing healthcare providers with respect to finding optimal treatments for patients with non-healing wounds.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.
A team of researchers from the Center for Disease Dynamics, Economics & Policy, USA, and Johns Hopkins University, USA, found evidence to support the notion that increased humidity may have contributed to lesser cases in spring earlier this year (2020). However, as the winter season fast approaches, the researchers fear that the decreasing humidity is likely to lead to an increase in COVID-19 cases.
Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
› Verified 7 days ago
Dr. Peter Nyitray, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2100 Wescott Dr, Department Of Anesthesia, Flemington, NJ 08822 Phone: 908-788-6410 Fax: 908-788-6361 | |
Chia-lung Lai, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-788-6100 | |
William Earl Bentley Iv, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2100 Wescott Dr, Hunterdon Medical Ctr-anesthesia Office, Flemington, NJ 08822 Phone: 908-788-6181 | |
Patricio Sonza, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-788-6100 | |
Dr. Walter Lapicki, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-788-6410 Fax: 908-236-0637 | |
Mrs. Ramya Krishnan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-688-6181 | |
Dr. Preethi Gurudatt Kamath, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-235-2859 |